Pittenger & Anderson Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,024 shares of the medical equipment provider’s stock after purchasing an additional 1,023 shares during the quarter. Pittenger & Anderson Inc.’s holdings in Intuitive Surgical were worth $2,310,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Adviser Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $115,000. Signet Financial Management LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $115,000. Arrow Financial Corp acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $115,000. Optimum Investment Advisors grew its stake in Intuitive Surgical by 189.9% in the 3rd quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock valued at $131,000 after acquiring an additional 150 shares during the period. Finally, McKinley Carter Wealth Services Inc. acquired a new stake in Intuitive Surgical in the 1st quarter valued at $132,000. 84.80% of the stock is currently owned by institutional investors and hedge funds.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 35,672 shares of the firm’s stock in a transaction on Monday, August 6th. The stock was sold at an average price of $520.24, for a total value of $18,558,001.28. Following the transaction, the chief executive officer now owns 363,542 shares in the company, valued at approximately $189,129,090.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Jamie Samath sold 862 shares of the firm’s stock in a transaction on Tuesday, July 24th. The shares were sold at an average price of $523.40, for a total value of $451,170.80. Following the completion of the transaction, the vice president now owns 257 shares in the company, valued at approximately $134,513.80. The disclosure for this sale can be found here. Insiders sold a total of 109,463 shares of company stock worth $57,194,982 in the last 90 days. 2.20% of the stock is currently owned by insiders.
Shares of ISRG stock opened at $532.02 on Friday. The firm has a market capitalization of $65.29 billion, a price-to-earnings ratio of 73.99, a PEG ratio of 4.20 and a beta of 0.89. Intuitive Surgical, Inc. has a fifty-two week low of $350.00 and a fifty-two week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share for the quarter, beating analysts’ consensus estimates of $2.02 by $0.74. The company had revenue of $909.30 million for the quarter, compared to analyst estimates of $877.43 million. Intuitive Surgical had a return on equity of 20.56% and a net margin of 23.20%. The firm’s revenue for the quarter was up 19.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.95 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 9.31 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on the stock. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 31st. Citigroup lifted their price target on shares of Intuitive Surgical from $561.00 to $592.00 and gave the company a “buy” rating in a research note on Thursday, August 2nd. Zacks Investment Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 19th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, July 20th. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and issued a $575.00 price target on shares of Intuitive Surgical in a research note on Friday, July 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $538.51.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Article: Google Finance Portfolio
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.